• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒中性内肽酶基因传递联合紫杉醇治疗前列腺癌。

Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.

机构信息

Genitourinary Oncology Research Laboratory, Department of Medicine, Weill Cornell Medical College and Weill Cornell Cancer Center, New York, NY, USA.

出版信息

Int J Oncol. 2012 Oct;41(4):1192-8. doi: 10.3892/ijo.2012.1586. Epub 2012 Aug 8.

DOI:10.3892/ijo.2012.1586
PMID:22895534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3583657/
Abstract

Neutral endopeptidase (NEP) is a cell-surface peptidase that inhibits prostate cancer cell growth partly via inhibition of Akt kinase. We investigated the antitumor effects of an adenovirus gene delivery system (AdNEP) to restore NEP expression in DU145 prostate cancer cells in combination with paclitaxel chemotherapy. DU145 cells were infected with adenovirus expressing NEP or LacZ, treated with paclitaxel, and assessed for cell viability, Akt activation and induction of apoptosis. Athymic mice with established DU145 xenografts were injected intratumorally with AdNEP or AdLacZ and intraperitoneally with paclitaxel and monitored for tumor growth over 28 days. Compared to AdLacZ plus paclitaxel, AdNEP plus paclitaxel significantly inhibited DU145 cell growth and increased apoptosis as determined by increased caspase-3 and PARP-1 proteolytic fragments. In a xenograft model, tumor volume was reduced in mice treated with AdNEP plus paclitaxel (122.85±89.5 mm3; P<0.01) compared with mice treated with AdNEP plus saline (653.9±230.3 mm3), AdLacZ plus paclitaxel (575.9±176.6 mm3) or AdLacZ plus saline (920.2±238.2 mm3). In conclusion, these data suggest that NEP can augment taxane-induced apoptosis through inhibition of Akt/Bad signaling, and that the combination of NEP plus paclitaxel may be an effective strategy to inhibit castration-resistant prostate cancer growth.

摘要

中性内肽酶(NEP)是一种细胞表面肽酶,通过抑制 Akt 激酶来部分抑制前列腺癌细胞生长。我们研究了腺病毒基因传递系统(AdNEP)恢复 DU145 前列腺癌细胞中 NEP 表达,与紫杉醇化疗联合治疗的抗肿瘤作用。将表达 NEP 或 LacZ 的腺病毒感染 DU145 细胞,用紫杉醇处理,并评估细胞活力、Akt 激活和诱导凋亡。将已建立的 DU145 异种移植物的裸鼠瘤内注射 AdNEP 或 AdLacZ,并腹腔内注射紫杉醇,并在 28 天内监测肿瘤生长。与 AdLacZ 加紫杉醇相比,AdNEP 加紫杉醇显着抑制 DU145 细胞生长并增加凋亡,这是通过增加 caspase-3 和 PARP-1 蛋白水解片段来确定的。在异种移植模型中,与 AdNEP 加生理盐水(653.9±230.3 mm3)、AdLacZ 加紫杉醇(575.9±176.6 mm3)或 AdLacZ 加生理盐水(920.2±238.2 mm3)相比,用 AdNEP 加紫杉醇治疗的小鼠肿瘤体积减少(122.85±89.5 mm3;P<0.01)。综上所述,这些数据表明 NEP 可以通过抑制 Akt/Bad 信号转导增强紫杉烷诱导的凋亡,并且 NEP 加紫杉醇的组合可能是抑制去势抵抗性前列腺癌生长的有效策略。

相似文献

1
Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.腺病毒中性内肽酶基因传递联合紫杉醇治疗前列腺癌。
Int J Oncol. 2012 Oct;41(4):1192-8. doi: 10.3892/ijo.2012.1586. Epub 2012 Aug 8.
2
Lentiviral vector neutral endopeptidase gene transfer suppresses prostate cancer tumor growth.慢病毒载体中性内肽酶基因转移抑制前列腺癌肿瘤生长。
Cancer Gene Ther. 2007 Jun;14(6):583-9. doi: 10.1038/sj.cgt.7701047. Epub 2007 Apr 6.
3
Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis.中性内肽酶通过减少成纤维细胞生长因子-2(FGF-2)介导的血管生成来抑制前列腺癌的肿瘤发生。
Prostate Cancer Prostatic Dis. 2008;11(1):79-87. doi: 10.1038/sj.pcan.4500984. Epub 2007 Jun 12.
4
Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.中性内肽酶的缺失和蛋白激酶B(Akt)的激活与前列腺癌进展相关。
Cancer. 2006 Dec 1;107(11):2628-36. doi: 10.1002/cncr.22312.
5
Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.在临床前胰腺癌模型中,通过抑制胰岛素样生长因子(IGF)信号通路增强对纳米白蛋白结合型紫杉醇的反应。
Oncotarget. 2016 Jul 26;7(30):46988-47001. doi: 10.18632/oncotarget.9029.
6
Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.中性内肽酶在雄激素非依赖性前列腺癌细胞中的肿瘤抑制作用。
Clin Cancer Res. 2001 May;7(5):1370-7.
7
Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.PTEN基因疗法与放疗联合可抑制人前列腺癌异种移植瘤的生长。
Hum Gene Ther. 2006 Oct;17(10):975-84. doi: 10.1089/hum.2006.17.975.
8
Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.甲基亚硒酸增强紫杉烷类药物对人前列腺癌的疗效,并下调抗凋亡蛋白Bcl-XL和生存素。
Clin Cancer Res. 2008 Feb 15;14(4):1150-8. doi: 10.1158/1078-0432.CCR-07-4037.
9
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.前列腺癌特异性腺病毒CV787与紫杉醇和多西他赛的抗肿瘤协同作用。
Cancer Res. 2001 Jan 15;61(2):517-25.
10
A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer.一种新型硒核苷通过靶向紫杉醇耐药前列腺癌中的 Skp2 降解来抑制肿瘤生长。
Biochem Pharmacol. 2018 Dec;158:84-94. doi: 10.1016/j.bcp.2018.10.002. Epub 2018 Oct 5.

引用本文的文献

1
Neprilysin regulates the progression of glioblastoma: an in-vitro study using siRNA mediated gene silencing and HDAC1 mediated upregulation of neprilysin in U87 MG cells.中性内肽酶调节胶质母细胞瘤的进展:一项在U87 MG细胞中使用小干扰RNA介导的基因沉默和组蛋白去乙酰化酶1介导的中性内肽酶上调的体外研究。
Mol Cell Biochem. 2025 Jun 29. doi: 10.1007/s11010-025-05341-9.
2
Membrane metalloendopeptidase suppresses prostate carcinogenesis by attenuating effects of gastrin-releasing peptide on stem/progenitor cells.膜金属内肽酶通过减弱胃泌素释放肽对干细胞/祖细胞的作用来抑制前列腺癌发生。
Oncogenesis. 2020 Mar 23;9(3):38. doi: 10.1038/s41389-020-0222-3.
3

本文引用的文献

1
Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer.简明综述:中性内肽酶(CD10):干细胞、生理机制和癌症中多方面的环境作用因子。
Stem Cells. 2011 Mar;29(3):389-96. doi: 10.1002/stem.592.
2
The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells.淀粉样前体蛋白信号和组蛋白去乙酰化酶抑制对人前列腺细胞内啡肽酶表达的影响。
Int J Cancer. 2012 Feb 15;130(4):775-86. doi: 10.1002/ijc.26028. Epub 2011 Jun 18.
3
Casein kinase 2 dependent phosphorylation of neprilysin regulates receptor tyrosine kinase signaling to Akt.
Long-term neprilysin inhibition - implications for ARNIs.
长期 Neprilysin 抑制 - ARNIs 的影响。
Nat Rev Cardiol. 2017 Mar;14(3):171-186. doi: 10.1038/nrcardio.2016.200. Epub 2016 Dec 15.
4
shRNA-mediated GSTP1 gene silencing enhances androgen-independent cell line DU145 chemosensitivity.短发夹RNA介导的谷胱甘肽S-转移酶P1基因沉默增强雄激素非依赖性细胞系DU145的化学敏感性。
Int Urol Nephrol. 2014 Jun;46(6):1115-21. doi: 10.1007/s11255-013-0616-7. Epub 2013 Dec 11.
5
Novel gene delivery systems.新型基因递送系统。
Int J Pharm Investig. 2013 Jan;3(1):1-7. doi: 10.4103/2230-973X.108958.
酪蛋白激酶 2 依赖性神经肽酶的磷酸化调节受体酪氨酸激酶信号转导至 Akt。
PLoS One. 2010 Oct 1;5(10):e13134. doi: 10.1371/journal.pone.0013134.
4
Rational redesign of neutral endopeptidase binding to merlin and moesin proteins.与默林蛋白和埃兹蛋白结合的中性内肽酶的合理重新设计。
Protein Sci. 2009 May;18(5):1042-50. doi: 10.1002/pro.114.
5
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].一项针对局限性前列腺癌的I/II期临床试验,该试验使用一种表达硝基还原酶并联合CB1954[纠正为CB1954]的腺病毒。
Mol Ther. 2009 Jul;17(7):1292-9. doi: 10.1038/mt.2009.80. Epub 2009 Apr 14.
6
Role of the Akt pathway in prostate cancer.Akt信号通路在前列腺癌中的作用。
Curr Cancer Drug Targets. 2009 Mar;9(2):163-75. doi: 10.2174/156800909787581006.
7
Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.Akt2/生存素通路作为紫杉醇治疗人卵巢癌细胞的关键靶点的意义。
Cancer Lett. 2009 Jan 18;273(2):257-65. doi: 10.1016/j.canlet.2008.08.027. Epub 2008 Oct 7.
8
The Ezrin-radixin-moesin family member ezrin regulates stable microtubule formation and retroviral infection.埃兹蛋白-根蛋白-膜突蛋白家族成员埃兹蛋白调节稳定微管形成和逆转录病毒感染。
J Virol. 2008 May;82(9):4665-70. doi: 10.1128/JVI.02403-07. Epub 2008 Feb 27.
9
Taxanes, microtubules and chemoresistant breast cancer.紫杉烷类、微管与化疗耐药性乳腺癌
Biochim Biophys Acta. 2008 Apr;1785(2):96-132. doi: 10.1016/j.bbcan.2007.10.004. Epub 2007 Nov 12.
10
Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis.中性内肽酶通过减少成纤维细胞生长因子-2(FGF-2)介导的血管生成来抑制前列腺癌的肿瘤发生。
Prostate Cancer Prostatic Dis. 2008;11(1):79-87. doi: 10.1038/sj.pcan.4500984. Epub 2007 Jun 12.